Evaluation of ONCOXIN® in Oral Mucositis, Appetite and Body Mass in Cancer Patients.

PHASE2CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

November 1, 2017

Primary Completion Date

May 31, 2018

Study Completion Date

July 15, 2018

Conditions
Mucositis Oral
Interventions
DIETARY_SUPPLEMENT

Oncoxin®

Chemo-, radiotherapy or their combination + standard oral mucositis treatment + ONCOXIN 25 ml twice daily for 20 days;

Trial Locations (1)

4433030

Medical Scientific centre of professor Shumsky, Samara

All Listed Sponsors
lead

Catalysis SL

INDUSTRY

NCT03577535 - Evaluation of ONCOXIN® in Oral Mucositis, Appetite and Body Mass in Cancer Patients. | Biotech Hunter | Biotech Hunter